133 related articles for article (PubMed ID: 22539583)
1. Telomere abnormalities and chromosome fragility in patients affected by familial papillary thyroid cancer.
Cantara S; Pisu M; Frau DV; Caria P; Dettori T; Capezzone M; Capuano S; Vanni R; Pacini F
J Clin Endocrinol Metab; 2012 Jul; 97(7):E1327-31. PubMed ID: 22539583
[TBL] [Abstract][Full Text] [Related]
2. Short telomeres, telomerase reverse transcriptase gene amplification, and increased telomerase activity in the blood of familial papillary thyroid cancer patients.
Capezzone M; Cantara S; Marchisotta S; Filetti S; De Santi MM; Rossi B; Ronga G; Durante C; Pacini F
J Clin Endocrinol Metab; 2008 Oct; 93(10):3950-7. PubMed ID: 18664542
[TBL] [Abstract][Full Text] [Related]
3. Telomere length and telomerase reverse transcriptase gene copy number in patients with papillary thyroid carcinoma.
Jendrzejewski J; Tomsic J; Lozanski G; Labanowska J; He H; Liyanarachchi S; Nagy R; Ringel MD; Kloos RT; Heerema NA; de la Chapelle A
J Clin Endocrinol Metab; 2011 Nov; 96(11):E1876-80. PubMed ID: 21900378
[TBL] [Abstract][Full Text] [Related]
4. Telomere length in neoplastic and nonneoplastic tissues of patients with familial and sporadic papillary thyroid cancer.
Capezzone M; Cantara S; Marchisotta S; Busonero G; Formichi C; Benigni M; Capuano S; Toti P; Pazaitou-Panayiotou K; Caruso G; Carli AF; Palummo N; Pacini F
J Clin Endocrinol Metab; 2011 Nov; 96(11):E1852-6. PubMed ID: 21865371
[TBL] [Abstract][Full Text] [Related]
5. Lack of mutations of the telomerase RNA component in familial papillary thyroid cancer with short telomeres.
Cantara S; Capuano S; Capezzone M; Benigni M; Pisu M; Marchisotta S; Pacini F
Thyroid; 2012 Apr; 22(4):363-8. PubMed ID: 22304389
[TBL] [Abstract][Full Text] [Related]
6. Genetic Heterogeneity of HER2 Amplification and Telomere Shortening in Papillary Thyroid Carcinoma.
Caria P; Cantara S; Frau DV; Pacini F; Vanni R; Dettori T
Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27775641
[TBL] [Abstract][Full Text] [Related]
7. Papillary thyroid carcinoma associated with papillary renal neoplasia: genetic linkage analysis of a distinct heritable tumor syndrome.
Malchoff CD; Sarfarazi M; Tendler B; Forouhar F; Whalen G; Joshi V; Arnold A; Malchoff DM
J Clin Endocrinol Metab; 2000 May; 85(5):1758-64. PubMed ID: 10843148
[TBL] [Abstract][Full Text] [Related]
8. Telomere length is shorter in affected members of families with familial nonmedullary thyroid cancer.
He M; Bian B; Gesuwan K; Gulati N; Zhang L; Nilubol N; Kebebew E
Thyroid; 2013 Mar; 23(3):301-7. PubMed ID: 23009101
[TBL] [Abstract][Full Text] [Related]
9. Familial Papillary Thyroid Carcinoma (FPTC): a Retrospective Analysis in a Sample of the Bulgarian Population for a 10-Year Period.
Vidinov K; Nikolova D
Endocr Pathol; 2017 Mar; 28(1):54-59. PubMed ID: 27771834
[TBL] [Abstract][Full Text] [Related]
10. Inactivation of 14-3-3sigma influences telomere behavior and ionizing radiation-induced chromosomal instability.
Dhar S; Squire JA; Hande MP; Wellinger RJ; Pandita TK
Mol Cell Biol; 2000 Oct; 20(20):7764-72. PubMed ID: 11003671
[TBL] [Abstract][Full Text] [Related]
11. A Greek family with a follicular variant of familial papillary thyroid carcinoma: TCO, MNG1, fPTC/PRN, and NMTC1 excluded as susceptibility loci.
Tsilchorozidou T; Vafiadou E; Yovos JG; Romeo G; McKay J; Lesueur F; Bonora E
Thyroid; 2005 Dec; 15(12):1349-54. PubMed ID: 16405407
[TBL] [Abstract][Full Text] [Related]
12. Multiple HABP2 variants in familial papillary thyroid carcinoma: Contribution of a group of "thyroid-checked" controls.
Kern B; Coppin L; Romanet P; Crépin M; Szuster I; Renaud F; Leteurtre E; Frénois F; Wemeau JL; Carnaille B; Cardot-Bauters C; Do Cao C; Pigny P
Eur J Med Genet; 2017 Mar; 60(3):178-184. PubMed ID: 28089742
[TBL] [Abstract][Full Text] [Related]
13. [Biological characteristics and management of familial papillary thyroid carcinoma].
Zhao J; Yu Y; Xia TT; Liu YZ; Wei SF; Zheng XQ; Gao M
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Nov; 46(11):897-900. PubMed ID: 22335974
[TBL] [Abstract][Full Text] [Related]
14. Specific subtelomere loss on chromosome der(11)t(3;11)(q23;q23)x2 in anaplastic thyroid cancer cell line OCUT-1.
Kammori M; Onoda N; Nakamura K; Izumiyama N; Ogisawa K; Kurabayashi R; Ogawa T; Kaminishi M; Poon SS; Takubo K
Int J Mol Med; 2006 Jul; 18(1):9-16. PubMed ID: 16786150
[TBL] [Abstract][Full Text] [Related]
15. Role of Age at Diagnosis in Defining Potential Familial Nonmedullary Thyroid Cancer in Kindreds With Two Affected Members.
Capezzone M; Sagnella A; Pilli T; Maino F; Forleo R; Cantara S; Cartocci A; Castagna MG
J Clin Endocrinol Metab; 2021 Jan; 106(2):e855-e865. PubMed ID: 33175120
[TBL] [Abstract][Full Text] [Related]
16. In situ detection of hTERT mRNA relates to Ki-67 labeling index in papillary thyroid carcinoma.
Chou SJ; Chen CM; Harn HJ; Chen CJ; Liu YC
J Surg Res; 2001 Jul; 99(1):75-83. PubMed ID: 11421607
[TBL] [Abstract][Full Text] [Related]
17. Familial vs sporadic papillary thyroid carcinoma: a matched-case comparative study showing similar clinical/prognostic behaviour.
Pinto AE; Silva GL; Henrique R; Menezes FD; Teixeira MR; Leite V; Cavaco BM
Eur J Endocrinol; 2014 Feb; 170(2):321-7. PubMed ID: 24272198
[TBL] [Abstract][Full Text] [Related]
18. A report of six cases of familial papillary thyroid cancer.
Orsenigo E; Beretta E; Gini P; Verrecchia F; Invernizzi L; Fiorina P; Di Carlo V
Eur J Surg Oncol; 2003 Mar; 29(2):185-7. PubMed ID: 12633563
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological features and prognosis of familial papillary thyroid carcinoma--a large-scale, matched, case-control study.
Cao J; Chen C; Chen C; Wang QL; Ge MH
Clin Endocrinol (Oxf); 2016 Apr; 84(4):598-606. PubMed ID: 26191611
[TBL] [Abstract][Full Text] [Related]
20. Familial papillary thyroid carcinoma is genetically distinct from familial adenomatous polyposis coli.
Malchoff CD; Sarfarazi M; Tendler B; Forouhar F; Whalen G; Malchoff DM
Thyroid; 1999 Mar; 9(3):247-52. PubMed ID: 10211600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]